• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质类固醇:类固醇节省疗法时代的选择

Corticosteroids: options in the era of steroid-sparing therapy.

作者信息

Del Rosso James, Friedlander Sheila Fallon

机构信息

Department of Dermatology, University of Nevada School of Medicine, Las Vegas, Nevada, USA.

出版信息

J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S50-8. doi: 10.1016/j.jaad.2005.04.030.

DOI:10.1016/j.jaad.2005.04.030
PMID:15968264
Abstract

Topical corticosteroids remain the most commonly used topical treatments for inflammatory dermatoses, including psoriasis and atopic dermatitis. Topical corticosteroids are available in a variety of vehicles-creams, ointments, lotions, gels, and, more recently, foam. The vehicle used can substantially affect the individual agent's clinical action, potency, and acceptability to the patient. Moreover, some vehicles are better suited for specific body areas. Selection of the appropriate product should be determined by area of usage, physician experience, cost, and patient preference, particularly regarding vehicle. Although topical corticosteroids are associated with several side effects, including skin atrophy, telangiectases, purpura, and striae formation, appropriate usage can minimize these occurrences. Judicious use includes short-term, appropriate application as initial monotherapy or in combination strategies with other therapeutic agents that ideally possess complementing mechanisms of action. Examples include pulsing with high-potency topical corticosteroids and combination regimens with other topical agents such as topical calcineurin inhibitors, calcipotriene, or tazarotene. Appropriate education of patients and caregivers alike will facilitate the optimal use of these medications.

摘要

外用糖皮质激素仍然是治疗包括银屑病和特应性皮炎在内的炎症性皮肤病最常用的外用药物。外用糖皮质激素有多种剂型,如乳膏、软膏、洗剂、凝胶,最近还有泡沫剂。所使用的剂型会极大地影响单个药物的临床作用、效力以及患者的接受度。此外,一些剂型更适合特定的身体部位。合适产品的选择应根据使用部位、医生经验、成本以及患者偏好来决定,尤其是关于剂型的偏好。尽管外用糖皮质激素会引发多种副作用,包括皮肤萎缩、毛细血管扩张、紫癜和条纹形成,但合理使用可将这些情况的发生降至最低。明智的使用包括短期、适当地作为初始单一疗法使用,或与其他理想情况下具有互补作用机制的治疗药物联合使用。例子包括使用高效外用糖皮质激素进行脉冲治疗,以及与其他外用药物如外用钙调神经磷酸酶抑制剂、卡泊三醇或他扎罗汀联合使用。对患者和护理人员进行适当的教育将有助于这些药物的最佳使用。

相似文献

1
Corticosteroids: options in the era of steroid-sparing therapy.皮质类固醇:类固醇节省疗法时代的选择
J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S50-8. doi: 10.1016/j.jaad.2005.04.030.
2
Mechanisms of action of topical therapies and the rationale for combination therapy.局部治疗的作用机制及联合治疗的理论依据。
J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S17-25. doi: 10.1016/j.jaad.2005.04.027.
3
A clinician's paradigm in the treatment of atopic dermatitis.临床医生治疗特应性皮炎的范例。
J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S70-7. doi: 10.1016/j.jaad.2005.04.032.
4
Therapeutic options in the treatment of psoriasis and atopic dermatitis.银屑病和特应性皮炎的治疗选择
J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S3-16. doi: 10.1016/j.jaad.2005.04.026.
5
Topical application of calcipotriene and corticosteroids: combination regimens.卡泊三醇与皮质类固醇的局部应用:联合治疗方案
J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S55-8.
6
Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.一种用于治疗银屑病的新型局部皮质类固醇载体配方的临床研究。
J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S39-49. doi: 10.1016/j.jaad.2005.04.029.
7
Topical antipsoriatics.局部用抗银屑病药。
Skin Therapy Lett. 2000;5(2):1-2.
8
A clinician's paradigm in the treatment of psoriasis.临床医生治疗银屑病的范例。
J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S59-69. doi: 10.1016/j.jaad.2005.04.031.
9
Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.外用糖皮质激素和外用钙调神经磷酸酶抑制剂治疗特应性皮炎:聚焦经皮吸收
Am J Ther. 2009 May-Jun;16(3):264-73. doi: 10.1097/MJT.0b013e31818a975c.
10
[Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].[外用糖皮质激素与银屑病管理中的糖皮质激素节约疗法]
Acta Med Croatica. 2007 Sep;61(4):375-81.

引用本文的文献

1
Rosmarinic Acid Ameliorates Extract-Induced Atopic Dermatitis-like Skin Inflammation by Activating the Nrf2/HO-1 Signaling Pathway.迷迭香酸通过激活Nrf2/HO-1信号通路改善提取物诱导的特应性皮炎样皮肤炎症。
Int J Mol Sci. 2024 Nov 27;25(23):12737. doi: 10.3390/ijms252312737.
2
The decoy oligodeoxynucleotide against HIF-1α and STAT5 ameliorates atopic dermatitis-like mouse model.针对缺氧诱导因子-1α(HIF-1α)和信号转导与转录激活因子5(STAT5)的诱饵寡脱氧核苷酸改善了特应性皮炎样小鼠模型。
Mol Ther Nucleic Acids. 2023 Sep 20;34:102036. doi: 10.1016/j.omtn.2023.102036. eCollection 2023 Dec 12.
3
The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update.
特应性皮炎中的免疫和结构表皮屏障功能障碍及皮肤微生物群——最新进展
Front Mol Biosci. 2023 Aug 16;10:1159404. doi: 10.3389/fmolb.2023.1159404. eCollection 2023.
4
Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis.揭示儿科特应性皮炎的关键药理学知识和策略。
Expert Rev Clin Pharmacol. 2023 Feb;16(2):119-131. doi: 10.1080/17512433.2023.2173172. Epub 2023 Feb 6.
5
Melittin-Carrying Nanoparticle Suppress T Cell-Driven Immunity in a Murine Allergic Dermatitis Model.载蜂毒素纳米颗粒抑制小鼠变应性皮肤病模型中的 T 细胞驱动免疫。
Adv Sci (Weinh). 2023 Mar;10(7):e2204184. doi: 10.1002/advs.202204184. Epub 2023 Jan 13.
6
Leaf Extract Alleviates Atopic Dermatitis through the Suppression of T Cells and Keratinocytes Activation.叶提取物通过抑制T细胞和角质形成细胞的活化来减轻特应性皮炎。
Pharmaceuticals (Basel). 2022 Oct 18;15(10):1280. doi: 10.3390/ph15101280.
7
The potential action of SSRIs in the treatment of skin diseases including atopic dermatitis and slow-healing wounds.SSRIs 在治疗皮肤病(包括特应性皮炎和愈合缓慢的伤口)方面的潜在作用。
Pharmacol Rep. 2022 Oct;74(5):947-955. doi: 10.1007/s43440-022-00423-7. Epub 2022 Oct 7.
8
New Strategies for Improving Budesonide Skin Retention.改善布地奈德皮肤滞留的新策略。
Pharmaceutics. 2021 Dec 24;14(1):30. doi: 10.3390/pharmaceutics14010030.
9
Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison.药物递送载体与化妆品保湿剂:综述与比较
Pharmaceutics. 2021 Nov 26;13(12):2012. doi: 10.3390/pharmaceutics13122012.
10
Gomisin M2 Ameliorates Atopic Dermatitis-like Skin Lesions via Inhibition of STAT1 and NF-κB Activation in 2,4-Dinitrochlorobenzene/ Extract-Induced BALB/c Mice.戈米辛 M2 通过抑制 2,4-二硝基氯苯/提取物诱导的 BALB/c 小鼠中的 STAT1 和 NF-κB 活化来改善特应性皮炎样皮肤损伤。
Molecules. 2021 Jul 21;26(15):4409. doi: 10.3390/molecules26154409.